Efficacy and Safety of Decitabine Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma
Status:
Unknown status
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
Primary objective of the study is to compare the efficacy and safety of decitabine plus CHOP
(D-CHOP) versus CHOP alone in patients with previously untreated peripheral T-cell lymphoma
(PTCL).